Fujita, H.; Miyadera, K.; Kato, M.; Fujioka, Y.; Ochiiwa, H.; Huang, J.; Ito, K.; Aoyagi, Y.; Takenaka, T.; Suzuki, T.; Ito, S.; Hashimoto, A.; Suefuji, T.; Egami, K.; Kazuno, H.; Suda, Y.; Nishio, K.; Yonekura, K. . (2013). The Novel VEGF Receptor/MET-Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Profile. Molecular Cancer Therapeutics, 12(12), 2685–2696.
doi:10.1158/1535-7163.mct-13-0459
